Skip to main content

Table 2 Cases of clinically affected patients/families with HAE-FXII (gender, age of onset, impact of estrogen)

From: Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence

Described by

Nucleotide change

Type of mutation

Protein change

No. of families

No. of patients

No. of males

No. of females

Age of onset (years)

No. of females impacted by estrogens

Origin of patients

Clear impact

No impact

Not exposed

Bork et al. [13]a

c.983C > A

Missense

p.Thr328Lys

23

69

1

68

20.3 ± 9.2 (mean ± SD)

48

10

10

Germany, Turkey, Brazil

c.983C > G

Missense

p.Thr328Arg

c.971_1018 + 24del72

Deletion

Indel

Cichon et al. [16]

c.983C > A

Missense

p.Thr328Lys

1

4

0

4

nr

nr

nr

nr

France

Martin et al. [17]

c.983C > A

Missense

p.Thr328Lys

1

4

2

2

nr

2

0

0

France

Bouillet et al. [18]

c.983C > A

Missense

p.Thr328Lys

1

2

0

2

19 (from 1/2 pts)

2

0

0

France

Bell et al. [19]

c.983C > A

Missense

p.Thr328Lys

1

1

0

1

20

0

1

0

Australia

Duan et al. [20]b

c.983C > A

Missense

p.Thr328Lys

1

7

0

7

nr

7

0

0

Italy

Prieto et al. [21]

c.983C > A

Missense

p.Thr328Lys

1

4

0

4

35 (from 1/4 pts)

4

0

0

Spain

Hentges et al. [22]

c.983C > A

Missense

p.Thr328Lys

1

1

0

1

nr

1

0

0

Luxembourg

Nagy et al. [23]

c.983C > A

Missense

p.Thr328Lys

1

3

0

3

nr

2

1

0

Italy

Picone et al. [24]

c.983C > A

Missense

p.Thr328Lys

2

5

0

5

nr

3

2

0

France

Baeza et al. [25]

c.983C > A

Missense

p.Thr328Lys

1

3

0

3

20 (from 1/3 pts)

3

0

0

Morroco

Marcos et al. [26]

c.983C > A

Missense

p.Thr328Lys

13

29

3

26

23.9 (14–55) (mean[range])

25

1

0

Spain

Kiss et al. [15]

c.892_909dup

Duplication

p.Pro298_Pro303dup

1

1

0

1

35

0

1

0

Hungary

Gomez-Traseira et al. [27]

c.983C > A

Missense

p.Thr328Lys

1

5

0

5

22.8 (mean)

5

0

0

Spain

Charignon et al. [28]

c.983C > A

Missense

p.Thr328Lys

40

80

8

72

24.3 (mean; from 69/80 pts)e

nr

nr

nr

France, Spain

Moreno et al. [29]

c.983C > A

Missense

p.Thr328Lys

4

8

1

7

13.9 (mean)e

7

0

0

Brazil

Mansi et al. [30]

c.983C > A

Missense

p.Thr328Lys

3

3

nr

nr

nr

nr

nr

nr

Italy

Stieber et al. [31]

c.983C > A

Missense

p.Thr328Lys

1

12

0

12

27 (mean; from 7/12 pts)e

4

nr

nr

Brazil

Moreno et al. [32]

c.983C > A

Missense

p.Thr328Lys

1

1

0

1

16

1

0

0

Brazil

Deroux et al. [33]

c.983C > A

Missense

p.Thr328Lys

24

37

1

36

21. ± 7.27 (mean ± SD)e

32

4

0

France

Grumach et al. [34]

c.983C > A

Missense

p.Thr328Lys

2

14

4

10

27.7 (mean; from 12/14 pts)

8

2

0

Brazil

Piñero-Saavedra et al. [35]

c.983C > A

Missense

p.Thr328Lys

9

24

3

21

19.9 (mean; from 16/21 f); 61.5 (mean; from 2/3 m)

19

nr

nr

Spain

Bork et al. [36]c

c.983C > A

Missense

p.Thr328Lys

1

4

0

4

nr

nr

nr

nr

Germany

Veronez et al. [37]

c.971_1018 + 24del72

Deletion

Indel

1

1

1

0

68

0

0

1f

Brazil

Veronez et al. [38]

c.983C > A

Missense

p.Thr328Lys

41

101

15

86

21.1 ± 11.7 (2–68) (mean ± SD [range])

59

nr

nr

Brazil

Bova et al. [39]d

c.983C > A

Missense

p.Thr328Lys

9

23

0

23

21 (5–76) (median [range])

20

3

0

Italy

  1. C1-INH = C1 esterase inhibitor, F = females, FXII = coagulation factor XII, Indel = insertion/deletion, Lys = lysine, M = males, No. = Number; nr = not reported, Pro = proline, pts = patients, SD = standard deviation, Thr = threonine
  2. aArticle also includes all patients described in Dewald and Bork [7], Bork et al. [8], Bork et al. [14], Bork et al. [40], and Bork et al. [41]
  3. bThis family has been described by Binkley and Davis [5]
  4. cBesides the here mentioned family, this article includes patients published in [13]
  5. dThis article includes a patient series published by Firinu et al. [42]
  6. eRecalculated
  7. f1 male patient exposed to an ACE inhibitor [37]